TURP Work RVU for 2026
I cannot provide specific Work RVU (Relative Value Unit) information for TURP in 2026, as the evidence provided consists entirely of clinical guidelines and research studies regarding the medical management, indications, techniques, and outcomes of the procedure—not Medicare reimbursement or RVU data.
What I Can Tell You About TURP Based on Available Evidence
TURP remains the gold standard surgical treatment for moderate-to-severe lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), particularly for prostates ≤80 grams. 1
Current Clinical Context
- The number of TURP procedures has declined significantly over recent decades due to increased use of medical therapy with alpha-blockers and 5-alpha-reductase inhibitors 2
- Despite this decline, TURP continues to be indicated for patients with absolute indications including renal insufficiency secondary to BPH, refractory urinary retention, recurrent UTIs, recurrent bladder stones, and gross hematuria due to BPH 3, 4
- Both monopolar and bipolar TURP techniques are acceptable, with bipolar TURP having reduced risk of TUR syndrome and hyponatremia 3, 4
Where to Find RVU Information
For accurate 2026 Work RVU values for TURP (CPT code 52601), you should consult:
- CMS Physician Fee Schedule - Released annually, typically in November for the following year
- AMA RUC (Relative Value Scale Update Committee) recommendations
- Medicare Administrative Contractors (MACs) in your region
The Work RVU values are determined by CMS based on physician work (time, technical skill, mental effort, judgment, and stress) and are subject to annual updates through the Medicare Physician Fee Schedule rulemaking process.